2020 Update on MPNs: What Is the Risk Adapted Management in PV? Is Ropeginterferon Alfa-2b Effective in Inducing CHR? Can We Achieve Both HCT Control and Spleen Response With Ruxolitinib?

117 views
December 10, 2020
Comments 0
Login to view comments. Click here to Login